# A Phase I Study of PepGNP-ChikV in Healthy Volunteers

> **NCT07394426** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Gylden Pharma Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Chikungunya
- Chikungunya Fever
- Chikungunya Virus Infection
- Chikungunya Virus Infections
- Chikungunya Virus

## Interventions

- **BIOLOGICAL:** PepGNP-ChikV
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07394426
- **Lead sponsor:** Gylden Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07394426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07394426, "A Phase I Study of PepGNP-ChikV in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07394426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*